Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TrtNH-PEG5-NHTrt | Login | TrtNH-PEG5-NHTrt | ||||||||||||||||
|
||||||||||||||||||
TrtNH-PEG8-NHTrt | Login | TrtNH-PEG8-NHTrt | ||||||||||||||||
|
||||||||||||||||||
Drosophila Diptericin Inhibitor TPS-17 | Login | Drosophila Diptericin Inhibitor TPS-17 | ||||||||||||||||
|
||||||||||||||||||
Drosophila Diptericin Inhibitor TPS-19 | Login | Drosophila Diptericin Inhibitor TPS-19 | ||||||||||||||||
|
||||||||||||||||||
Anti INI1/BAF47/SNF5 | Login | Anti INI1/BAF47/SNF5 | ||||||||||||||||
|
||||||||||||||||||
Anti DHX9/RNA helicase A | Login | Anti DHX9/RNA helicase A | ||||||||||||||||
|
||||||||||||||||||
Anti Histone H3.1/H3.2 | Login | Anti Histone H3.1/H3.2 | ||||||||||||||||
|
||||||||||||||||||
Anti Histone H3.1/H3.2 | Login | Anti Histone H3.1/H3.2 | ||||||||||||||||
|
||||||||||||||||||
Anti Histone H3.3 | Login | Anti Histone H3.3 | ||||||||||||||||
|
||||||||||||||||||
Anti GNA11 | Login | Anti GNA11 | ||||||||||||||||
|
||||||||||||||||||
Anti HRG | Login | Anti HRG | ||||||||||||||||
|
||||||||||||||||||
Anti NAP1L2 | Login | Anti NAP1L2 | ||||||||||||||||
|
||||||||||||||||||
Anti NAP1L3 | Login | Anti NAP1L3 | ||||||||||||||||
|
||||||||||||||||||
Anti NAPRT1 | Login | Anti NAPRT1 | ||||||||||||||||
|
||||||||||||||||||
Anti TGFBI | Login | Anti TGFBI | ||||||||||||||||
|
||||||||||||||||||
Anti TNFAIP8L2 | Login | Anti TNFAIP8L2 | ||||||||||||||||
|
||||||||||||||||||
Anti TUBGCP2 | Login | Anti TUBGCP2 | ||||||||||||||||
|
||||||||||||||||||
Anti CUTL1 | Login | Anti CUTL1 | ||||||||||||||||
|
||||||||||||||||||
Anti NAP1L2 | Login | Anti NAP1L2 | ||||||||||||||||
|
||||||||||||||||||
Anti NAP1L3 | Login | Anti NAP1L3 | ||||||||||||||||
|
||||||||||||||||||
Anti NAPRT1 | Login | Anti NAPRT1 | ||||||||||||||||
|
||||||||||||||||||
Anti PDCD1 | Login | Anti PDCD1 | ||||||||||||||||
|
||||||||||||||||||
Anti RAD51L1 | Login | Anti RAD51L1 | ||||||||||||||||
|
||||||||||||||||||
Anti TGFBI | Login | Anti TGFBI | ||||||||||||||||
|
||||||||||||||||||
Anti TUBGCP2 | Login | Anti TUBGCP2 | ||||||||||||||||
|